SCNI
Scinai Immunotherapeutics Ltd
NASDAQ: SCNI · HEALTHCARE · BIOTECHNOLOGY
$0.74
+3.67% today
Updated 2026-04-30
Market cap
$2.06M
P/E ratio
0.00
P/S ratio
1.58x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$0 – $3
Volume
4.1M
WallStSmart proprietary scores
48
out of 100
Grade: C
Sell
Investment rating
8.3
Growth
A4.0
Quality
C2.5
Profitability
F6.7
Valuation
B3/9
Piotroski F-Score
Weak
-12.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$700.00
+94494.59%
12-Month target
$0.75
+1.35%
Intrinsic (DCF)
$1.59
Margin of safety
+52.83%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 30.60% QoQ
+ 52.83% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -12.31 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-6.05M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $658000.00 | $1.31M | $1.31M |
| Net income | $-5.80M | $-6.50M | $4.80M | $-8.31M | $-2.05M |
| EPS | — | — | — | — | $0.00 |
| Free cash flow | $-8.10M | $-10.02M | $-6.35M | $-6.05M | $-6.05M |
| Profit margin | — | — | 728.88% | -633.64% | — |
Peer comparison
Smart narrative
Scinai Immunotherapeutics Ltd trades at $0.74. Our Smart Value Score of 48/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -12.31, it sits in the distress. TTM revenue stands at $1.31M. Our DCF model estimates intrinsic value at $1.59.
Frequently asked questions
What is Scinai Immunotherapeutics Ltd's stock price?
Scinai Immunotherapeutics Ltd (SCNI) trades at $0.74.
Is Scinai Immunotherapeutics Ltd overvalued?
Smart Value Score 48/100 (Grade C, Sell). DCF value $1.59.
What is the price target of Scinai Immunotherapeutics Ltd (SCNI)?
The analyst target price is $700.00, representing +94494.6% upside from the current price of $0.74.
What is the intrinsic value of Scinai Immunotherapeutics Ltd (SCNI)?
Based on our DCF model, intrinsic value is $1.59, a +52.8% margin of safety versus $0.74.
What is Scinai Immunotherapeutics Ltd's revenue?
TTM revenue is $1.31M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-12.31 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.58x
ROE-91.90%
Beta1.99
50D MA$0.68
200D MA$1.13
Shares out0.00B
Float12.21B
Short ratio—
Avg volume4.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—